M. Inci Et Al. , "Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report," ACTA NEUROLOGICA BELGICA , vol.122, no.5, pp.1389-1391, 2022
Inci, M. Et Al. 2022. Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report. ACTA NEUROLOGICA BELGICA , vol.122, no.5 , 1389-1391.
Inci, M., GÜNDÜZ, T., Kurtuncu, M., & Eraksoy, M., (2022). Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report. ACTA NEUROLOGICA BELGICA , vol.122, no.5, 1389-1391.
Inci, Meltem Et Al. "Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report," ACTA NEUROLOGICA BELGICA , vol.122, no.5, 1389-1391, 2022
Inci, Meltem Et Al. "Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report." ACTA NEUROLOGICA BELGICA , vol.122, no.5, pp.1389-1391, 2022
Inci, M. Et Al. (2022) . "Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report." ACTA NEUROLOGICA BELGICA , vol.122, no.5, pp.1389-1391.
@article{article, author={Meltem Inci Et Al. }, title={Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report}, journal={ACTA NEUROLOGICA BELGICA}, year=2022, pages={1389-1391} }